Otsuka breaks up with cancer candidates on strategic grounds
Otsuka has broken up with a clutch of clinical cancer candidates. The Japanese drugmaker said strategic reasons—the pharma equivalent of “it’s not you, it’s me”—underpinned the decision to ax the assets.
Otsuka has broken up with a clutch of clinical cancer candidates. The Japanese drugmaker said strategic reasons—the pharma equivalent of “it’s not you, it’s me”—underpinned the decision to ax the assets.
